Kobayashi E, Doi H, Yoneyama T, Hamanaka H, Gibson I R, Best S M, Shelton J C, Bonfield W
Institute for Medical and Dental Engineering, Tokyo Medical and Dental University, Kanda-surugadai, Chiyoda-ku, Tokyo 101, Japan.
J Mater Sci Mater Med. 1998 Nov;9(11):625-30. doi: 10.1023/a:1008927407556.
Titanium-zirconium based alloys containing a small amount of niobium were investigated in order to evaluate their possible use as biomedical materials. Zirconium, which belongs to the IVa group, is known to have good corrosion resistance and biocompatibility similar to titanium. As the titanium-zirconium system shows a complete solid solution, a wide variation of alloy design is available and large quantities of solid-solution hardening must be possible. Niobium, having a beta-phase stabilizing effect, was chosen as a ternary element in order to control desirably the microstructure. There have been no reports which suggest its harm to a living body. The alloys containing 2% or 3% niobium showed the highest hardness value after aging heat treatment at 773 K. In contrast to this, no alteration of hardness was seen in specimens aged at 1073 K. Through conventional X-ray diffractometry and in situ X-ray analysis using a hot stage, beta-phase precipitation in the A matrix was identified. From the above results, it is concluded that alloys containing 2%-3% niobium are hopeful candidates for new kinds of biomedical alloys, when they are heat treated under suitable conditions.
为了评估含少量铌的钛锆基合金作为生物医学材料的潜在用途,对其进行了研究。锆属于IVa族,已知具有与钛相似的良好耐腐蚀性和生物相容性。由于钛锆体系呈现完全固溶体,合金设计有很大的变化范围,并且大量的固溶强化必然是可行的。铌具有β相稳定作用,被选为三元元素以理想地控制微观结构。没有报告表明其对生物体有危害。含2%或3%铌的合金在773K时效热处理后显示出最高硬度值。与此形成对比的是,在1073K时效的试样中未观察到硬度变化。通过传统X射线衍射法和使用热台的原位X射线分析,确定了A基体中的β相析出。根据上述结果得出结论,含2%-3%铌的合金在适当条件下进行热处理时,有望成为新型生物医学合金的候选材料。